<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334442</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Aggravating mechanisms from COVID-19.</ArticleTitle><Pagination><StartPage>228</StartPage><MedlinePgn>228</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">228</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-024-02506-8</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces immune-mediated diseases. The pathophysiology of COVID-19 uses the following three mechanisms: (1) inflammasome activation mechanism; (2) cGAS-STING signaling mechanism; and (3) SAMHD1 tetramerization mechanism, which leads to IFN-I production. Interactions between the host and virus govern induction, resulting in multiorgan impacts. The NLRP3 with cGAS-STING constitutes the primary immune response. The expression of SARS-CoV-2 ORF3a, NSP6, NSP7, and NSP8 blocks innate immune activation and facilitates virus replication by targeting the RIG-I/MDA5, TRIF, and cGAS-STING signaling. SAMHD1 has a target motif for CDK1 to protect virion assembly, threonine 592 to modulate a catalytically active tetramer, and antiviral IFN responses to block retroviral infection. Plastic and allosteric nucleic acid binding of SAMHD1 modulates the antiretroviral activity of SAMHD1. Therefore, inflammasome activation, cGAS-STING signaling, and SAMHD1 tetramerization explain acute kidney injury, hepatic, cardiac, neurological, and gastrointestinal injury of COVID-19. It might be necessary to effectively block the pathological courses of diverse diseases.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong Hoon</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Science and Research Center, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. science@research.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatrics, Gyeonggi Medical Center Pocheon Hospital, 1648 Pocheon-ro Sin-eup-dong, Pocheon-si, Gyeonggi-do, 11142, Republic of Korea. science@research.re.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sergi</LastName><ForeName>Consolato</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Anatomical Pathology, Children's Hospital of Eastern Ontario (CHEO), University of Ottawa, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kast</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>IIAIGC Study Center, 11 Arlington Ct, Burlington, 05408 VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanwar</LastName><ForeName>Badar A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Haider Associates, 1999 Forest Ridge Dr, Bedford, TX, 76021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourbeau</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Sangsuk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Food Engineering, Food Safety Laboratory, Memory Unit, Ewha Womans University, Seoul, 03670, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohn</LastName><ForeName>Mun-Gi</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Food Science, KyungHee University College of Life Science, Seoul, 17104, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chul Joong</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>College of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK. m.d.coleman@aston.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C578390">cGAS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="D000076106">SAM Domain and HD Domain-Containing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D009713">Nucleotidyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532857">STING1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="C484280">SAMHD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="Y">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076106" MajorTopicYN="N">SAM Domain and HD Domain-Containing Protein 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009713" MajorTopicYN="N">Nucleotidyltransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CGAS–STING</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Inflammasome</Keyword><Keyword MajorTopicYN="N">NLRP3</Keyword><Keyword MajorTopicYN="N">SAMHD1</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334442</ArticleId><ArticleId IdType="pmc">PMC11430051</ArticleId><ArticleId IdType="doi">10.1186/s12985-024-02506-8</ArticleId><ArticleId IdType="pii">10.1186/s12985-024-02506-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kakavandi S, et al. Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. Cell Commun Signal. 2023;21:110. 10.1186/s12964-023-01104-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10183699</ArticleId><ArticleId IdType="pubmed">37189112</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Mukherjee G, Mukherjee S. Chemotherapy vs. Immunotherapy in combating nCOVID19: an update. Hum Immunol. 2021;82:649–58. 10.1016/j.humimm.2021.05.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8130497</ArticleId><ArticleId IdType="pubmed">34020832</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463–9. 10.1038/s41586-020-2588-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney OJ, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202:812–21. 10.1164/rccm.202005-1583OC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52:910–41. 10.1016/j.immuni.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites RS, et al. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol. 2021;6:eabg9873. 10.1126/sciimmunol.abg9873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128298</ArticleId><ArticleId IdType="pubmed">33692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarczak D, Nierhaus A. Cytokine Storm&amp;mdash;definition, causes, and implications. Int J Mol Sci. 2022;23:11740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9570384</ArticleId><ArticleId IdType="pubmed">36233040</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P, et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat Commun. 2021;12:4664. 10.1038/s41467-021-25015-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329225</ArticleId><ArticleId IdType="pubmed">34341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, et al. Caspase-1-responsive fluorescence biosensors for monitoring endogenous inflammasome activation. Biosens Bioelectron. 2023;219:114812. 10.1016/j.bios.2022.114812.</Citation><ArticleIdList><ArticleId IdType="pubmed">36272346</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio JD, et al. The cGAS–STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022;603:145–51. 10.1038/s41586-022-04421-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Xu P. Cellular functions of cGAS–STING signaling. Trends Cell Biol. 2023;33:630–48. 10.1016/j.tcb.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">36437149</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, et al. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS–STING pathway and the interferon response. Sci Signal. 2022;15:eabg8744. 10.1126/scisignal.abg8744.</Citation><ArticleIdList><ArticleId IdType="pubmed">35412852</ArticleId></ArticleIdList></Reference><Reference><Citation>Coquel F, et al. SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature. 2018;557:57–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">29670289</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GI, et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009;41:829–32. 10.1038/ng.373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4154505</ArticleId><ArticleId IdType="pubmed">19525956</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15:429–40. 10.1038/nri3850.</Citation><ArticleIdList><ArticleId IdType="pubmed">26052098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, et al. Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children. Science. 2023;379:eabo3627. 10.1126/science.abo3627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10451000</ArticleId><ArticleId IdType="pubmed">36538032</ArticleId></ArticleIdList></Reference><Reference><Citation>Stillman B. Deoxynucleoside triphosphate (dNTP) synthesis and destruction regulate the replication of both cell and virus genomes. Proc Natl Acad Sci. 2013;110:14120–1. 10.1073/pnas.1312901110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3761580</ArticleId><ArticleId IdType="pubmed">23946423</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2020. 10.1084/jem.20201707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, Zamboni DS. Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation. Curr Opin Immunol. 2023;84:102387. 10.1016/j.coi.2023.102387.</Citation><ArticleIdList><ArticleId IdType="pubmed">37703588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T, Yamazaki T, Koshiba T, Yanagi Y. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A. 2013;110:17963–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3816452</ArticleId><ArticleId IdType="pubmed">24127597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YC, et al. SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19. Infection. 2023. 10.1007/s15010-023-02142-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11143065</ArticleId><ArticleId IdType="pubmed">38133713</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M-H, Lin X-L, Xiao L-L. SARS-CoV-2 nucleocapsid protein promotes TMAO-induced NLRP3 inflammasome activation by SCAP–SREBP signaling pathway. Tissue Cell. 2024;86:102276. 10.1016/j.tice.2023.102276.</Citation><ArticleIdList><ArticleId IdType="pubmed">37979395</ArticleId></ArticleIdList></Reference><Reference><Citation>Villacampa A, et al. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells. Cell Commun Signal. 2024;22:38. 10.1186/s12964-023-01397-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788971</ArticleId><ArticleId IdType="pubmed">38225643</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008;31:252–6. 10.1016/j.jaut.2008.04.017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3178062</ArticleId><ArticleId IdType="pubmed">18502610</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Rojas MI, et al. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med. 2011;105:1648–54. 10.1016/j.rmed.2011.05.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">21763119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira AC, et al. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discovery. 2021;7:43. 10.1038/s41420-021-00428-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919254</ArticleId><ArticleId IdType="pubmed">33649297</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, et al. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol. 2013;191:4358–66. 10.4049/jimmunol.1301170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848201</ArticleId><ArticleId IdType="pubmed">24048902</ArticleId></ArticleIdList></Reference><Reference><Citation>Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol. 2021;21:694–703. 10.1038/s41577-021-00588-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8351223</ArticleId><ArticleId IdType="pubmed">34373622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T, Yamazaki T, Koshiba T, Yanagi Y. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci. 2013;110:17963–8. 10.1073/pnas.1312571110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3816452</ArticleId><ArticleId IdType="pubmed">24127597</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmacke NA, et al. IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network. Immunity. 2022. 10.1016/j.immuni.2022.10.021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614333</ArticleId><ArticleId IdType="pubmed">36384135</ArticleId></ArticleIdList></Reference><Reference><Citation>Okondo MC, et al. Inhibition of Dpp8/9 activates the Nlrp1b inflammasome. Cell Chem Biol. 2018;25:262-267.e265. 10.1016/j.chembiol.2017.12.013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856610</ArticleId><ArticleId IdType="pubmed">29396289</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira Mann CC, Hopfner K-P. Nuclear cGAS: guard or prisoner? EMBO J. 2021;40:e108293. 10.15252/embj.2021108293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365253</ArticleId><ArticleId IdType="pubmed">34250619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H, et al. Micronucleus production, activation of DNA damage response and cGAS–STING signaling in syncytia induced by SARS-CoV-2 infection. Biol Direct. 2021;16:20. 10.1186/s13062-021-00305-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530504</ArticleId><ArticleId IdType="pubmed">34674770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, et al. COVID-19 molecular pathophysiology: acetylation of repurposing drugs. Int J Mol Sci. 2022;23:13260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9656873</ArticleId><ArticleId IdType="pubmed">36362045</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeldt CJ, et al. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS–STING and NF-κB. Commun Biol. 2022;5:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755718</ArticleId><ArticleId IdType="pubmed">35022513</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, et al. The porcine cyclic GMP-AMP Synthase-STING pathway exerts an unusual antiviral function independent of interferon and autophagy. J Virol. 2022. 10.1128/jvi.01476-22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749457</ArticleId><ArticleId IdType="pubmed">36377876</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Snyder SH, Bohr VA. Signaling by cGAS–STING in neurodegeneration, neuroinflammation, and aging. Trends Neurosci. 2021;44:83–96. 10.1016/j.tins.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662531</ArticleId><ArticleId IdType="pubmed">33187730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanwar B, Lee CJ, Lee J-H. Specific treatment exists for SARS-CoV-2 ARDS. Vaccines. 2021;9:635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8229893</ArticleId><ArticleId IdType="pubmed">34200720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferren M, et al. Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection. Nat Commun. 2021;12:5809. 10.1038/s41467-021-26096-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490365</ArticleId><ArticleId IdType="pubmed">34608167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin AC. Neuroinflammation and the cGAS–STING pathway. J Neurophysiol. 2019;121:1087–91. 10.1152/jn.00848.2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">30673358</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulen MF, et al. cGAS–STING drives ageing-related inflammation and neurodegeneration. Nature. 2023;620:374–80. 10.1038/s41586-023-06373-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10412454</ArticleId><ArticleId IdType="pubmed">37532932</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Ji X, Wu L, Xiong Y. Impaired dNTPase activity of SAMHD1 by phosphomimetic mutation of Thr-592. J Biol Chem. 2015;290:26352–9. 10.1074/jbc.M115.677435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646291</ArticleId><ArticleId IdType="pubmed">26294762</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux A, et al. FOXO1 transcription factor plays a key role in T cell—HIV-1 interaction. PLoS Pathog. 2019;15: e1007669. 10.1371/journal.ppat.1007669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6513100</ArticleId><ArticleId IdType="pubmed">31042779</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzolin E, Salata C, Bianchi V, Rampazzo C. The deoxynucleoside triphosphate triphosphohydrolase activity of SAMHD1 protein contributes to the mitochondrial DNA depletion associated with genetic deficiency of deoxyguanosine kinase *. J Biol Chem. 2015;290:25986–96. 10.1074/jbc.M115.675082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646252</ArticleId><ArticleId IdType="pubmed">26342080</ArticleId></ArticleIdList></Reference><Reference><Citation>White TE, et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe. 2013;13:441–51. 10.1016/j.chom.2013.03.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3864637</ArticleId><ArticleId IdType="pubmed">23601106</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L. Cellular and biochemical mechanisms of the retroviral restriction factor SAMHD1. Int Sch Res Not. 2013;2013:728392. 10.1155/2013/728392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918895</ArticleId><ArticleId IdType="pubmed">24523981</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, et al. SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathways. Proc Natl Acad Sci. 2018;115:E3798–807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910870</ArticleId><ArticleId IdType="pubmed">29610295</ArticleId></ArticleIdList></Reference><Reference><Citation>Cingöz O, Arnow ND, Puig Torrents M, Bannert N. Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection. Retrovirology. 2021;18:4. 10.1186/s12977-021-00548-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7871410</ArticleId><ArticleId IdType="pubmed">33563288</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J, et al. HIV-2/SIV Vpx targets a novel functional domain of STING to selectively inhibit cGAS–STING-mediated NF-κB signalling. Nat Microbiol. 2019;4:2552–64. 10.1038/s41564-019-0585-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">31659299</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajide OA, Iwuanyanwu VU, Adegbola OD, Al-Hindawi AA. SARS-CoV-2 spike glycoprotein S1 induces neuroinflammation in BV-2 microglia. Mol Neurobiol. 2021. 10.1007/s12035-021-02593-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8551352</ArticleId><ArticleId IdType="pubmed">34709564</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz EA, et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol Psychiatry. 2022. 10.1038/s41380-022-01831-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-H, Choi S-H, Lee CJ, Oh S-S. Recovery of dementia syndrome following treatment of brain inflammation. Dement Geriatr Cogn Disord Extra. 2020;10:1–12. 10.1159/000504880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7011720</ArticleId><ArticleId IdType="pubmed">32158462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Lee CJ, Park J, Lee SJ, Choi SH. The neuroinflammasome in Alzheimer’s disease and cerebral stroke. Dement Geriatr Cogn Dis Extra. 2021;11:159–67. 10.1159/000516074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255751</ArticleId><ArticleId IdType="pubmed">34249072</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckman D, et al. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep. 2022. 10.1016/j.celrep.2022.111573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9554328</ArticleId><ArticleId IdType="pubmed">36288725</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol. 2020;92:2105–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267663</ArticleId><ArticleId IdType="pubmed">32383269</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz JE, et al. Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nat Genet. 2022;54:382–92. 10.1038/s41588-021-01006-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005345</ArticleId><ArticleId IdType="pubmed">35241825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucia M, et al. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner. Leukemia. 2021. 10.1038/s41375-021-01332-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8219510</ArticleId><ArticleId IdType="pubmed">34163002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H, Pääbo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. 2020;587:610–2. 10.1038/s41586-020-2818-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32998156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rannikko EH, Weber SS, Kahle PJ. Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci. 2015;16:57. 10.1186/s12868-015-0192-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562100</ArticleId><ArticleId IdType="pubmed">26346361</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscat SM, Barrientos RM. The perfect cytokine storm: how peripheral immune challenges impact brain plasticity &amp; memory function in aging. Brain Plasticity. 2021;7:47–60. 10.3233/BPL-210127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461734</ArticleId><ArticleId IdType="pubmed">34631420</ArticleId></ArticleIdList></Reference><Reference><Citation>Manik M, Singh RK. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Virol. 2022;94:869–77. 10.1002/jmv.27405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662021</ArticleId><ArticleId IdType="pubmed">34672376</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank MG, et al. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties. Brain Behav Immun. 2022;100:267–77. 10.1016/j.bbi.2021.12.007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte C. Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4. Int J Mol Sci. 2021;22:7135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269350</ArticleId><ArticleId IdType="pubmed">34281186</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurgens HA, Amancherla K, Johnson RW. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci. 2012;32:3958–68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3353809</ArticleId><ArticleId IdType="pubmed">22442063</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka N, Cortese GP, Barrientos RM, Maier SF, Patterson SL. Aging and an immune challenge interact to produce prolonged, but not permanent, reductions in hippocampal L-LTP and mBDNF in a rodent model with features of delirium. Eneuro. 2018. 10.1523/ENEURO.0009-18.2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6001264</ArticleId><ArticleId IdType="pubmed">29911174</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861–5. 10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856–60. 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 Is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735–45. 10.1016/S0092-8674(00)81402-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9529250</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzolio S, et al. Neuropilin-1–dependent regulation of EGF-receptor signaling. Can Res. 2012;72:5801–11. 10.1158/0008-5472.Can-12-0995.</Citation><ArticleIdList><ArticleId IdType="pubmed">22986738</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF. Cytokine. 2005;32:206–12. 10.1016/j.cyto.2005.09.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">16289960</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita A, Gotze T, Korc M. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res. 2007;67:10309–16. 10.1158/0008-5472.Can-07-3256.</Citation><ArticleIdList><ArticleId IdType="pubmed">17974973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulpice E, et al. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood. 2008;111:2036–45. 10.1182/blood-2007-04-084269.</Citation><ArticleIdList><ArticleId IdType="pubmed">18065694</ArticleId></ArticleIdList></Reference><Reference><Citation>Slomiany MG, Black LA, Kibbey MM, Day TA, Rosenzweig SA. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun. 2006;342:851–8. 10.1016/j.bbrc.2006.02.043.</Citation><ArticleIdList><ArticleId IdType="pubmed">16499871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball SG, Bayley C, Shuttleworth CA, Kielty CM. Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells. Biochem J. 2010;427:29–40. 10.1042/bj20091512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3441150</ArticleId><ArticleId IdType="pubmed">20102335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherafat A, Pfeiffer F, Reiss AM, Wood WM, Nishiyama A. Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor. Nat Commun. 2021;12:2265. 10.1038/s41467-021-22532-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050320</ArticleId><ArticleId IdType="pubmed">33859199</ArticleId></ArticleIdList></Reference><Reference><Citation>Glinka Y, Prud’homme GJ. Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity. J Leukocyte Biol. 2008;84:302–10. 10.1189/jlb.0208090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2504713</ArticleId><ArticleId IdType="pubmed">18436584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, et al. Environmentally-induced &lt;i&gt;mdig&lt;/i&gt; contributes to the severity of COVID-19 through fostering expression of SARS-CoV-2 receptor NRPs and glycan metabolism. Theranostics. 2021;11:7970–83. 10.7150/thno.62138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315075</ArticleId><ArticleId IdType="pubmed">34335974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler N, Simons M. The expanding role of neuropilin: regulation of transforming growth factor-β and platelet-derived growth factor signaling in the vasculature. Curr Opin Hematol. 2016;23:260–7. 10.1097/moh.0000000000000233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4957701</ArticleId><ArticleId IdType="pubmed">26849476</ArticleId></ArticleIdList></Reference><Reference><Citation>Theobald SJ, et al. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol Med. 2021;13:e14150. 10.15252/emmm.202114150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8350892</ArticleId><ArticleId IdType="pubmed">34133077</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisfeld HS, et al. Viral glycoproteins induce NLRP3 inflammasome activation and pyroptosis in macrophages. Viruses. 2021;13:2076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8538122</ArticleId><ArticleId IdType="pubmed">34696506</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz GA, et al. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021;326:1210–2. 10.1001/jama.2021.13443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340007</ArticleId><ArticleId IdType="pubmed">34347001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak MZ, et al. SARS-CoV-2 entry receptor ACE2 Is expressed on very small CD45—precursors of hematopoietic and endothelial cells and in response to virus spike protein activates the NLRP3 inflammasome. Stem Cell Reviews and Reports. 2021;17:266–77. 10.1007/s12015-020-10010-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370872</ArticleId><ArticleId IdType="pubmed">32691370</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully M, et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384:2202–11. 10.1056/NEJMoa2105385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112532</ArticleId><ArticleId IdType="pubmed">33861525</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti SS, et al. Rapidly progressive dementia with asymmetric rigidity following ChAdOx1 nCoV-19 vaccination. Aging Dis. 2021. 10.14336/ad.2021.1102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9116920</ArticleId><ArticleId IdType="pubmed">35656106</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz NH, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384:2124–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 2009;458:509–13. 10.1038/nature07710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2862225</ArticleId><ArticleId IdType="pubmed">19158676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaidt, M. M. et al. The DNA inflammasome in human myeloid cells is initiated by a STING-Cell death program upstream of NLRP3. Cell171, 1110–1124.e1118 (2017). 10.1016/j.cell.2017.09.039</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901709</ArticleId><ArticleId IdType="pubmed">29033128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fengjuan Li NWYZYLYZ. cGAS- stimulator of interferon genes signaling in central nervous system disorders. Aging Dis. 2021;12:1658–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460300</ArticleId><ArticleId IdType="pubmed">34631213</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, et al. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J Med Viro. 2022;94:5174–88. 10.1002/jmv.27965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350412</ArticleId><ArticleId IdType="pubmed">35765167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yum S, Li M, Fang Y, Chen ZJ. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections. Proc Natl Acad Sci. 2021;118:e2100225118. 10.1073/pnas.2100225118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040795</ArticleId><ArticleId IdType="pubmed">33785602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, et al. Nuclear cGAS functions non-canonically to enhance antiviral immunity via recruiting methyltransferase Prmt5. Cell Rep. 2020;33:108490. 10.1016/j.celrep.2020.108490.</Citation><ArticleIdList><ArticleId IdType="pubmed">33296647</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao D, et al. The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING. Sci Signal. 2023;16:eadd0082. 10.1126/scisignal.add0082.</Citation><ArticleIdList><ArticleId IdType="pubmed">37130168</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J, et al. SARS-CoV-2 ORF3a inhibits cGAS–STING-mediated autophagy flux and antiviral function. J Med Virol. 2023;95:e28175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538343</ArticleId><ArticleId IdType="pubmed">36163413</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao P, et al. SARS-CoV-2 nonstructural protein 6 triggers endoplasmic reticulum stress-induced autophagy to degrade STING1. Autophagy. 2023;19:3113–31. 10.1080/15548627.2023.2238579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10621274</ArticleId><ArticleId IdType="pubmed">37482689</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, et al. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways. J Med Virol. 2021;93:5376–89. 10.1002/jmv.27050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y, et al. Unique and complementary suppression of cGAS–STING and RNA sensing-triggered innate immune responses by SARS-CoV-2 proteins. Signal Transduct Target Ther. 2021;6:123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7958565</ArticleId><ArticleId IdType="pubmed">33723219</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, et al. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways. J Med Virol. 2023;95:e28561. 10.1002/jmv.28561.</Citation><ArticleIdList><ArticleId IdType="pubmed">36755358</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, et al. SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways. J Med Virol. 2023;95:e28680. 10.1002/jmv.28680.</Citation><ArticleIdList><ArticleId IdType="pubmed">36929724</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphries F, et al. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol. 2021;6:eabi9002. 10.1126/sciimmunol.abi9002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158975</ArticleId><ArticleId IdType="pubmed">34010139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji X, et al. Mechanism of allosteric activation of SAMHD1 by dGTP. Nat Struct Mol Biol. 2013;20:1304–9. 10.1038/nsmb.2692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833828</ArticleId><ArticleId IdType="pubmed">24141705</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Tang Y-D, Zheng C. When cyclin-dependent kinases meet viral infections, including SARS-CoV-2. J Med Virol. 2022;94:2962–8. 10.1002/jmv.27719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088476</ArticleId><ArticleId IdType="pubmed">35288942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta RK, Mlcochova P. Cyclin D3 restricts SARS-CoV-2 envelope incorporation into virions and interferes with viral spread. EMBO J. 2022;41:e111653. 10.15252/embj.2022111653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9539236</ArticleId><ArticleId IdType="pubmed">36161661</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A, Sergi C. SAMHD1 as the potential link between SARS-CoV-2 infection and neurological complications. Front Neurol. 2020;11:562913. 10.3389/fneur.2020.562913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546029</ArticleId><ArticleId IdType="pubmed">33101175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen NE, et al. Structural and functional characterization explains loss of dNTPase activity of the cancer-specific R366C/H mutant SAMHD1 proteins. J Biol Chem. 2021. 10.1016/j.jbc.2021.101170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497992</ArticleId><ArticleId IdType="pubmed">34492268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CH, et al. Nucleic acid binding by SAMHD1 contributes to the antiretroviral activity and is enhanced by the GpsN modification. Nat Commun. 2021;12:731. 10.1038/s41467-021-21023-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854603</ArticleId><ArticleId IdType="pubmed">33531504</ArticleId></ArticleIdList></Reference><Reference><Citation>Maelfait J, Bridgeman A, Benlahrech A, Cursi C, Rehwinkel J. Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1. Cell Rep. 2016;16:1492–501. 10.1016/j.celrep.2016.07.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978700</ArticleId><ArticleId IdType="pubmed">27477283</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Lopez A, et al. SAMHD1 deficient human monocytes autonomously trigger type I interferon. Mol Immunol. 2018;101:450–60. 10.1016/j.molimm.2018.08.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6258080</ArticleId><ArticleId IdType="pubmed">30099227</ArticleId></ArticleIdList></Reference><Reference><Citation>Espada CE, et al. SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection. J Biol Chem. 2023;299:104925. 10.1016/j.jbc.2023.104925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10404699</ArticleId><ArticleId IdType="pubmed">37328105</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo A, et al. Elimination of Aicardi–Goutières syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication. J Biol Chem. 2022. 10.1016/j.jbc.2022.101635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786443</ArticleId><ArticleId IdType="pubmed">35085552</ArticleId></ArticleIdList></Reference><Reference><Citation>Berri F, et al. Early plasma interferon-β levels as a predictive marker of COVID-19 severe clinical events in adult patients. J Med Virol. 2023;95: e28361. 10.1002/jmv.28361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9877952</ArticleId><ArticleId IdType="pubmed">36451263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JYY, et al. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients. Sci Rep. 2021;11:4533. 10.1038/s41598-021-83366-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907391</ArticleId><ArticleId IdType="pubmed">33633121</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH. Treatment mechanism of immune triad from the repurposing drug against COVID-19. Trans Med Aging. 2023;7:33–45. 10.1016/j.tma.2023.06.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290163</ArticleId><ArticleId IdType="pubmed">37388715</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020;53:425–35. 10.1016/j.jmii.2020.04.015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201239</ArticleId><ArticleId IdType="pubmed">32414646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, et al. Racial health disparity and COVID-19. J Neuroimmune Pharmacol. 2021;16:729–42. 10.1007/s11481-021-10014-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426163</ArticleId><ArticleId IdType="pubmed">34499313</ArticleId></ArticleIdList></Reference><Reference><Citation>Chlamydas S, Papavassiliou AG, Piperi C. Epigenetic mechanisms regulating COVID-19 infection. Epigenetics. 2021;16:263–70. 10.1080/15592294.2020.1796896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901548</ArticleId><ArticleId IdType="pubmed">32686577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128:1323–6. 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Das NC, Patra R, Mukherjee S. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans. J Med Virol. 2021;93:2476–86. 10.1002/jmv.26776.</Citation><ArticleIdList><ArticleId IdType="pubmed">33404091</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra R, Chandra Das N, Mukherjee S. Targeting human TLRs to combat COVID-19: A solution? J Med Virol. 2021;93:615–7. 10.1002/jmv.26387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436140</ArticleId><ArticleId IdType="pubmed">32749702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, et al. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021;31:818–20. 10.1038/s41422-021-00495-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975240</ArticleId><ArticleId IdType="pubmed">33742149</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirvaliloo M. The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks. Epigenomics. 2022;14:153–62. 10.2217/epi-2021-0476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8763212</ArticleId><ArticleId IdType="pubmed">35021853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronstein-Wiedemann R, et al. SARS-CoV-2 infects red blood cell progenitors and dysregulates hemoglobin and iron metabolism. Stem Cell Reviews and Reports. 2022;18:1809–21. 10.1007/s12015-021-10322-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8856880</ArticleId><ArticleId IdType="pubmed">35181867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez JJI, et al. TLR4 sensing of IsdB of Staphylococcus aureus induces a proinflammatory cytokine response via the NLRP3-caspase-1 inflammasome cascade. eBio. 2023. 10.1128/mbio.00225-23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10790753</ArticleId><ArticleId IdType="pubmed">38112465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80. 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollica V, Rizzo A, Massari F. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Future Oncol. 2020;16:2029–33. 10.2217/fon-2020-0571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359420</ArticleId><ArticleId IdType="pubmed">32658591</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyrou I, Randeva HS, Spandidos DA, Karteris E. Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19. Signal Transduct Target Ther. 2021;6:21. 10.1038/s41392-020-00460-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7812344</ArticleId><ArticleId IdType="pubmed">33462185</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J, et al. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19. Mol Med Rep. 2020;22:4221–6. 10.3892/mmr.2020.11510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533503</ArticleId><ArticleId IdType="pubmed">33000221</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184:5932-5949.e5915. 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573–80. 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Group, S. C.-G. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383:1522–34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience. 2020;23:101160. 10.1016/j.isci.2020.101160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219414</ArticleId><ArticleId IdType="pubmed">32405622</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H, Pääbo S. A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Proc Natl Acad Sci. 2021;118: e2026309118. 10.1073/pnas.2026309118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936282</ArticleId><ArticleId IdType="pubmed">33593941</ArticleId></ArticleIdList></Reference><Reference><Citation>Clottu AS, Humbel M, Fluder N, Karampetsou MP, Comte D. Innate lymphoid cells in autoimmune diseases. Front Immunol. 2021;12: 789788. 10.3389/fimmu.2021.789788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8777080</ArticleId><ArticleId IdType="pubmed">35069567</ArticleId></ArticleIdList></Reference><Reference><Citation>Meininger I, et al. Tissue-specific features of innate lymphoid cells. Trends Immunol. 2020;41:902–17. 10.1016/j.it.2020.08.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">32917510</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323:2329–30. 10.1001/jama.2020.6825.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchese G, et al. Anti-neuronal antibodies against brainstem antigens are associated with COVID-19. EBioMedicine. 2022;83:104211. 10.1016/j.ebiom.2022.104211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9365397</ArticleId><ArticleId IdType="pubmed">35963198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerner G, Quintana-Murci L. The genetic and evolutionary determinants of COVID-19 susceptibility. Eur J Hum Genet. 2022;30:915–21. 10.1038/s41431-022-01141-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9244541</ArticleId><ArticleId IdType="pubmed">35760904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity. Nat Immunol. 2022;23:237–50. 10.1038/s41590-021-01097-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35075279</ArticleId></ArticleIdList></Reference><Reference><Citation>Spits H, Mjösberg J. Heterogeneity of type 2 innate lymphoid cells. Nat Rev Immunol. 2022;22:701–12. 10.1038/s41577-022-00704-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966870</ArticleId><ArticleId IdType="pubmed">35354980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano T, et al. T cell infiltration into the brain triggers pulmonary dysfunction in murine Cryptococcus-associated IRIS. Nat Commun. 2023;14:3831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10307837</ArticleId><ArticleId IdType="pubmed">37380639</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangarembizi R, Drummond R. Immune-related neurodegeneration in the midbrain causes pulmonary dysfunction in murine cryptococcal IRIS. Trends Neurosci. 2023;46:1003–4. 10.1016/j.tins.2023.09.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">37806831</ArticleId></ArticleIdList></Reference><Reference><Citation>Örd M, Faustova I, Loog M. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV. Sci Rep. 2020;10:16944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547067</ArticleId><ArticleId IdType="pubmed">33037310</ArticleId></ArticleIdList></Reference><Reference><Citation>Sergi CM, Chiu B. Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J Med Virol. 2021;93:669–70. 10.1002/jmv.26461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461176</ArticleId><ArticleId IdType="pubmed">32841451</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K, Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7:e06187. 10.1016/j.heliyon.2021.e06187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887388</ArticleId><ArticleId IdType="pubmed">33644468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586–92. 10.1126/science.abd4251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7464562</ArticleId><ArticleId IdType="pubmed">32694201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin U, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595:572–7. 10.1038/s41586-021-03653-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34044428</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22:757–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D, Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration. Biochem Biophys Res Commun. 2021;554:94–8. 10.1016/j.bbrc.2021.03.100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Young MJ, O’Hare M, Matiello M, Schmahmann JD. Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? Brain Behav Immun. 2020;89:601–3. 10.1016/j.bbi.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362815</ArticleId><ArticleId IdType="pubmed">32681865</ArticleId></ArticleIdList></Reference><Reference><Citation>Montezano AC, et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci Rep. 2023;13:14086. 10.1038/s41598-023-41115-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10462711</ArticleId><ArticleId IdType="pubmed">37640791</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, et al. SARS-CoV-2 spike protein–induced cell fusion activates the cGAS–STING pathway and the interferon response. Sci Signal. 2022;15:eabg8744.</Citation><ArticleIdList><ArticleId IdType="pubmed">35412852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyström S, Hammarström P. Amyloidogenesis of SARS-CoV-2 spike protein. J Am Chem Soc. 2022;144:8945–50. 10.1021/jacs.2c03925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakaran M, et al. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates. Sci Trans Med. 2024;16:eadd5960. 10.1126/scitranslmed.add5960.</Citation><ArticleIdList><ArticleId IdType="pubmed">38170789</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, et al. Omicron subvariants escape antibodies elicited by vaccination and BA. 2.2 infection. Lancet Infect Dis. 2022;22:1116–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212811</ArticleId><ArticleId IdType="pubmed">35738299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrkalska SD, et al. Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern. Sci Adv. 2022;8:eabo0732. 10.1126/sciadv.abo0732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9481140</ArticleId><ArticleId IdType="pubmed">36112681</ArticleId></ArticleIdList></Reference><Reference><Citation>Szebeni J, et al. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. Nat Nanotechnol. 2022;17:337–46. 10.1038/s41565-022-01071-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">35393599</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink DL, et al. HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65. Retrovirology. 2022;19:2. 10.1186/s12977-021-00586-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785589</ArticleId><ArticleId IdType="pubmed">35073912</ArticleId></ArticleIdList></Reference><Reference><Citation>Troili F, et al. Perivascular unit: this must be the place the anatomical crossroad between the immune, vascular and nervous system. Front Neuroanat. 2020;14:17. 10.3389/fnana.2020.00017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177187</ArticleId><ArticleId IdType="pubmed">32372921</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Computing the effects of SARS-CoV-2 on respiration regulatory mechanisms in COVID-19. ACS Chem Neurosci. 2020;11:2416–21. 10.1021/acschemneuro.0c00349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422910</ArticleId><ArticleId IdType="pubmed">32600045</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res. 2020;21:198. 10.1186/s12931-020-01462-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385717</ArticleId><ArticleId IdType="pubmed">32723327</ArticleId></ArticleIdList></Reference><Reference><Citation>Josselyn SA, Tonegawa S. Memory engrams: recalling the past and imagining the future. Science. 2020. 10.1126/science.aaw4325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577560</ArticleId><ArticleId IdType="pubmed">31896692</ArticleId></ArticleIdList></Reference><Reference><Citation>Koren T, et al. Insular cortex neurons encode and retrieve specific immune responses. Cell. 2021;184:5902-5915.e5917. 10.1016/j.cell.2021.10.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">34752731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogolla N. The brain remembers where and how inflammation struck. Cell. 2021;184:5851–3. 10.1016/j.cell.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">34822782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther. 2021;6:337. 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594-1610.e1511. 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepehrinezhad A, Gorji A, Sahab Negah S. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism. Inflammopharmacology. 2021. 10.1007/s10787-021-00845-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266993</ArticleId><ArticleId IdType="pubmed">34241783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M-H, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med. 2020;384:481–3. 10.1056/nejmc2033369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41:2657–69. 10.1007/s10072-020-04575-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385206</ArticleId><ArticleId IdType="pubmed">32725449</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA. Clinical and pathophysiologic spectrum of neuro-COVID. Mol Neurobiol. 2021;58:3787–91. 10.1007/s12035-021-02383-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026389</ArticleId><ArticleId IdType="pubmed">33829393</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J, et al. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep. 2020;47(6):4383–92. 10.1007/s11033-020-05478-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224351</ArticleId><ArticleId IdType="pubmed">32410141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-de San Luis C, Pezzoli M, Urrieta E, Ryan TJ. Engram cell connectivity as a mechanism for information encoding and memory function. Curr Biol. 2023;33:5368–80. 10.1016/j.cub.2023.10.074.</Citation><ArticleIdList><ArticleId IdType="pubmed">37992719</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Lopez JM, et al. Neuronal progenitors of the dentate gyrus express the SARS-CoV-2 cell receptor during migration in the developing human hippocampus. Cell Mol Life Sci. 2023;80:140. 10.1007/s00018-023-04787-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10164240</ArticleId><ArticleId IdType="pubmed">37149825</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R-C, et al. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J Neuroinflammation. 2022;19:149. 10.1186/s12974-022-02514-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-On L, Dekel H, Aftalion M, Chitlaru T, Erez N. Essential role for Batf3-dependent dendritic cells in regulating CD8 T-cell response during SARS-CoV-2 infection. PLoS ONE. 2023;18: e0294176. 10.1371/journal.pone.0294176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10752548</ArticleId><ArticleId IdType="pubmed">38150441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamari M, et al. Sensory neurons promote immune homeostasis in the lung. Cell. 2024;187:44-61.e17. 10.1016/j.cell.2023.11.027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10811756</ArticleId><ArticleId IdType="pubmed">38134932</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudd PA, et al. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020;6:eabe3024. 10.1126/sciadv.abe3024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725462</ArticleId><ArticleId IdType="pubmed">33187979</ArticleId></ArticleIdList></Reference><Reference><Citation>Monneret G, et al. COVID-19: What type of cytokine storm are we dealing with? J Med Virol. 2021;93:197–8. 10.1002/jmv.26317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405026</ArticleId><ArticleId IdType="pubmed">32681651</ArticleId></ArticleIdList></Reference><Reference><Citation>Horkowitz AP, et al. Acetylcholine regulates pulmonary pathology during viral infection and recovery. ImmunoTargets and Therapy. 2020;9:333–50. 10.2147/ITT.S279228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751717</ArticleId><ArticleId IdType="pubmed">33365281</ArticleId></ArticleIdList></Reference><Reference><Citation>Erttmann SF, et al. The gut microbiota prime systemic antiviral immunity via the cGAS–STING-IFN-I axis. Immunity. 2022;55:847-861.e810. 10.1016/j.immuni.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">35545033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabanyi I, et al. Bacterial sensing via neuronal Nod2 regulates appetite and body temperature. Science. 2022;376:eabj3986.</Citation><ArticleIdList><ArticleId IdType="pubmed">35420957</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Wang F, Cao Y, Dang Y, Ge B. The multifaceted functions of cGAS. J Mol Cell Biol. 2022. 10.1093/jmcb/mjac031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9475664</ArticleId><ArticleId IdType="pubmed">35536585</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz MA, et al. Human-derived air–liquid interface cultures decipher Alzheimer’s disease–SARS-CoV-2 crosstalk in the olfactory mucosa. J Neuroinflammation. 2023;20:299. 10.1186/s12974-023-02979-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10722731</ArticleId><ArticleId IdType="pubmed">38098019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Kanwar B, Lee CJ, Sergi C, Coleman MD. Dapsone is an anticatalysis for Alzheimer’s disease exacerbation. iScience. 2022. 10.1016/j.isci.2022.104274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9079171</ArticleId><ArticleId IdType="pubmed">35542045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, et al. Bronchitis, COPD, and pneumonia after viral endemic of patients with leprosy on Sorok Island in South Korea. Naunyn Schmiedebergs Arch Pharmacol. 2023. 10.1007/s00210-023-02407-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9918834</ArticleId><ArticleId IdType="pubmed">36773052</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim J, Park EK, Kim RK, Lee KH, Shin MR, Kwon Dh. the suspected coronavirus disease 2019 reinfection cases and vaccine effectiveness, The Republic of Korea. Public Health Weekly Rep. 2023;16:1504–20. 10.56786/PHWR.2023.16.44.2.</Citation></Reference><Reference><Citation>Axenhus M, Frederiksen KS, Zhou RZ, Waldemar G, Winblad B. The impact of the COVID-19 pandemic on mortality in people with dementia without COVID-19: a systematic review and meta-analysis. BMC Geriatr. 2022;22:878. 10.1186/s12877-022-03602-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9675075</ArticleId><ArticleId IdType="pubmed">36402953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, et al. Excess mortality with Alzheimer disease and related dementias as an underlying or contributing cause during the COVID-19 pandemic in the US. JAMA Neurol. 2023. 10.1001/jamaneurol.2023.2226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10352932</ArticleId><ArticleId IdType="pubmed">37459088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. h. et al. (Research Square, 2024).</Citation></Reference><Reference><Citation>Lee JH, et al. Basic implications on three pathways associated with SARS-CoV-2. Biomed J. 2024. 10.1016/j.bj.2024.100766.</Citation><ArticleIdList><ArticleId IdType="pubmed">39004185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>